GoodRx Holdings, Inc. (GDRX) earnings: date, estimates and history
Price $3.56 · data as of November 13, 2026
Next earnings report
Next reportNov 17, 2026
QuarterSep/2026
EPS estimate$0.04
Revenue estimate—
Expected EPS growth—
Track record
Beat EPS estimates1 of 4
Average surprise−3.9%
Average move on report day±8.7%
GoodRx beat the consensus earnings estimate in 1 of its last 4 reports, by −3.9% on average. On report days the stock moved 8.7% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 3, 2026 Sep/2026 | $0.04 | $0.04 | — | — | — | +4.8% |
| August 5, 2026 Jun/2026 | $0.08 | $0.08 | +0.4% | $200M | −1.3% | +11.4% |
| May 6, 2026 Mar/2026 | $0.07 | $0.07 | −2.2% | $194M | −4.4% | +10.9% |
| February 25, 2026 Dec/2025 | $0.09 | $0.09 | −1.7% | $195M | −1.9% | −16.0% |
| November 4, 2025 Sep/2025 | $0.09 | $0.08 | −12.3% | $196M | +0.4% | +0.6% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is GoodRx’s next earnings date?
GoodRx is expected to report on November 17, 2026 (quarter Sep/2026).
What EPS do analysts expect next quarter?
The consensus estimate is $0.04 per share.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar